ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CADL Candel Therapeutics Inc

7,13
0,01 (0,14%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Candel Therapeutics Inc CADL NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,01 0,14% 7,13 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
7,0701 6,76 7,54 7,15 7,12
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202409:00GLOBEFDA Grants Orphan Drug Designation for CAN-3110 for the..
23/05/202418:00GLOBECandel Therapeutics Reports Prolonged Overall Survival in..
22/05/202409:00GLOBECandel Therapeutics to Present at the Jefferies Global..
20/05/202409:00GLOBECandel Therapeutics to Host Non-Small Cell Lung Cancer..
14/05/202409:00GLOBECandel Therapeutics Reports First Quarter 2024 Financial..
25/04/202409:00GLOBECandel Therapeutics Announces Upcoming Presentations at the..
11/04/202410:00GLOBECandel Therapeutics Receives FDA Orphan Drug Designation for..
09/04/202409:00GLOBECandel Therapeutics Presents Preclinical Data at AACR on..
04/04/202409:00GLOBECandel Therapeutics Announces Positive Interim Data from..
28/03/202417:05GLOBECandel Therapeutics Announces Oral Presentation During the..
28/03/202409:05GLOBECandel Therapeutics Reports Fourth Quarter and Full Year..
05/03/202418:30GLOBECandel Therapeutics Announces an Upcoming Presentation at..
13/02/202409:30GLOBECAN-3110 Receives FDA Fast Track Designation for Treatment..
05/02/202410:00GLOBECandel Therapeutics Sets Path to Success: Recent..
12/12/202310:58DJNCandel Therapeutics Shares Soar After FDA Fast Track of..
12/12/202310:00GLOBECandel Therapeutics Receives FDA Fast Track Designation for..
28/11/202311:00GLOBECandel Therapeutics Announces Restructuring to Prioritize..
09/11/202310:00GLOBECandel Therapeutics Reports Third Quarter 2023 Financial..
04/11/202309:00GLOBECandel Therapeutics Presents Preclinical Data from its..
03/11/202313:00GLOBECandel Therapeutics Announces Initial Positive Interim Data..
18/10/202312:00GLOBECandel Therapeutics Announces Nature Publication Showing..
27/09/202310:40GLOBECandel Therapeutics Announces Three Abstracts Accepted for..
26/09/202309:00GLOBECandel Therapeutics Reports Encouraging Initial Survival..
06/09/202309:00GLOBECandel Therapeutics to Participate in the H.C. Wainwright..
10/08/202309:00GLOBECandel Therapeutics Reports Second Quarter 2023 Financial..
02/08/202309:00GLOBECandel Therapeutics to Participate in the Canaccord Genuity..
13/06/202309:00GLOBECandel Therapeutics Announces It Expects to Report Topline..